Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Alessandra Latini, Massimiliano Fabbiani, Vanni Borghi, Gaetana Sterrantino, Alberto Giannetti, Patrizia Lorenzini, Laura Loiacono, Adriana Ammassari, Rita Bellagamba, Manuela Colafigli, Gabriella D’Ettorre, Simona Di Giambenedetto, Andrea Antinori, Mauro Zaccarelli

ABSTRACT

BACKGROUND: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-based (PI/r) dual therapy (DT). METHODS: Observational, retrospective switch study in patients successfully treated with triple drugs regimen. Patients switched to PI/r based DT [darunavir (DRV/r), lopinavir (LPV/r) or atazanavir (ATV/r)] plus a second drug: [raltegravir (RAL), maraviroc (MVC) etravirine (ETR), lamivudine (3TC) or tenofovir (TDF)] between 2009 and 2014 were included. The effect of each drug as well as other clinical and virological cofactors over treatment discontinuation (TD) was assessed using survival analysis. RESULTS: Overall, 376 patients were included with mean follow-up of 73 weeks. The most commonly used drugs in DT were DRV/r (63.0 %) and RAL (53.7 %). TD was observed in 77 (20,4 %) patients: 38 (10,1 %) virological failure, 35 (9,3 %) toxicity/intolerance (4 deaths) and 4 (1 %) interruptions for patients decision. At Cox Model, adjusted by demographic and laboratory variables, DRV/r and ATV/r significantly reduced the likelihood of TD and longer treatment was associated with lower risk, while low CD4 count at baseline and number of previous regimens with a higher risk. Moreover, RAL and 3TC use were significantly associated with lower TD by toxicity. CONCLUSIONS: In our clinical practice experience, switching virologically suppressed patients to PI/r based DT showed adequate safety and efficacy, so that it may be used in selected patients with specific medical needs. More... »

PAGES

401

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12879-016-1703-z

DOI

http://dx.doi.org/10.1186/s12879-016-1703-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030880501

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27515949


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-HIV Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiretroviral Therapy, Highly Active", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD4 Lymphocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Darunavir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Protease Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lamivudine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lopinavir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medication Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Raltegravir Potassium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tenofovir", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituti di Ricovero e Cura a Carattere Scientifico", 
          "id": "https://www.grid.ac/institutes/grid.414603.4", 
          "name": [
            "San Gallicano Dermatologic Institute (IRCCS), Clinic of Dermatology and Infectious Diseases, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Latini", 
        "givenName": "Alessandra", 
        "id": "sg:person.0654670657.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654670657.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera San Gerardo", 
          "id": "https://www.grid.ac/institutes/grid.415025.7", 
          "name": [
            "Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy", 
            "Division of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fabbiani", 
        "givenName": "Massimiliano", 
        "id": "sg:person.0727131026.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727131026.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Azienda Ospedaliero Universitaria, Clinic of Infectious Diseases, Modena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Borghi", 
        "givenName": "Vanni", 
        "id": "sg:person.01262750607.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262750607.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliero-Universitaria Careggi", 
          "id": "https://www.grid.ac/institutes/grid.24704.35", 
          "name": [
            "Division of Infectious Diseases, Careggi Hospital, Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sterrantino", 
        "givenName": "Gaetana", 
        "id": "sg:person.01151343322.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151343322.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "Clinical Department, National Institute for the Infectious Diseases \u201cLazzaro Spallanzani\u201d, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giannetti", 
        "givenName": "Alberto", 
        "id": "sg:person.01167611267.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167611267.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "Clinical Department, National Institute for the Infectious Diseases \u201cLazzaro Spallanzani\u201d, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lorenzini", 
        "givenName": "Patrizia", 
        "id": "sg:person.0630766224.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630766224.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "Clinical Department, National Institute for the Infectious Diseases \u201cLazzaro Spallanzani\u201d, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loiacono", 
        "givenName": "Laura", 
        "id": "sg:person.01226673662.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226673662.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "Clinical Department, National Institute for the Infectious Diseases \u201cLazzaro Spallanzani\u201d, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ammassari", 
        "givenName": "Adriana", 
        "id": "sg:person.01012755035.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012755035.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "Clinical Department, National Institute for the Infectious Diseases \u201cLazzaro Spallanzani\u201d, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bellagamba", 
        "givenName": "Rita", 
        "id": "sg:person.0647671457.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647671457.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituti di Ricovero e Cura a Carattere Scientifico", 
          "id": "https://www.grid.ac/institutes/grid.414603.4", 
          "name": [
            "San Gallicano Dermatologic Institute (IRCCS), Clinic of Dermatology and Infectious Diseases, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Colafigli", 
        "givenName": "Manuela", 
        "id": "sg:person.01204452374.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204452374.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Policlinico Universitario \u201cUmberto I\u201d, Clinic of Infectious Diseases, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "D\u2019Ettorre", 
        "givenName": "Gabriella", 
        "id": "sg:person.0657532603.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657532603.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Catholic University of the Sacred Heart", 
          "id": "https://www.grid.ac/institutes/grid.8142.f", 
          "name": [
            "Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Di Giambenedetto", 
        "givenName": "Simona", 
        "id": "sg:person.0655305216.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655305216.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "Clinical Department, National Institute for the Infectious Diseases \u201cLazzaro Spallanzani\u201d, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Antinori", 
        "givenName": "Andrea", 
        "id": "sg:person.0675523721.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675523721.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani", 
          "id": "https://www.grid.ac/institutes/grid.419423.9", 
          "name": [
            "Clinical Department, National Institute for the Infectious Diseases \u201cLazzaro Spallanzani\u201d, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zaccarelli", 
        "givenName": "Mauro", 
        "id": "sg:person.01160510471.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160510471.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s15010-015-0764-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000109765", 
          "https://doi.org/10.1007/s15010-015-0764-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-014-0173-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002540664", 
          "https://doi.org/10.1007/s40273-014-0173-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(14)70736-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003152007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1468-1293.2009.00752.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003494913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-200003310-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007926797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-200003310-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007926797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1468-1293.2012.00989.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015370595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0000000000000407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021587453"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0000000000000407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021587453"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7448/ias.17.4.19788", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021877518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7448/ias.17.4.19813", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022776262"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e3283324283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023348079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e3283324283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023348079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e3283324283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023348079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/hiv.12129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030900257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dkr504", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031544139"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(15)00097-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033533736"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(14)61170-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033681539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qai.0b013e31818c7e8e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036507163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qai.0b013e31818c7e8e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036507163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/aje/153.9.898", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036832909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dks057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039666385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7448/ias.17.4.19799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041103106"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0106221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042054138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e32834bbaa9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047934667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e32834bbaa9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047934667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7448/ias.17.4.19803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049402120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/aid.2011.0275", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059226372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/aid.2011.0336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059226409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/cid/ciw207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059467827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1310/hct1303-119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064986484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1310/hct1504-140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064986562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078600806", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-based (PI/r) dual therapy (DT).\nMETHODS: Observational, retrospective switch study in patients successfully treated with triple drugs regimen. Patients switched to PI/r based DT [darunavir (DRV/r), lopinavir (LPV/r) or atazanavir (ATV/r)] plus a second drug: [raltegravir (RAL), maraviroc (MVC) etravirine (ETR), lamivudine (3TC) or tenofovir (TDF)] between 2009 and 2014 were included. The effect of each drug as well as other clinical and virological cofactors over treatment discontinuation (TD) was assessed using survival analysis.\nRESULTS: Overall, 376 patients were included with mean follow-up of 73\u00a0weeks. The most commonly used drugs in DT were DRV/r (63.0\u00a0%) and RAL (53.7\u00a0%). TD was observed in 77 (20,4\u00a0%) patients: 38 (10,1\u00a0%) virological failure, 35 (9,3\u00a0%) toxicity/intolerance (4 deaths) and 4 (1\u00a0%) interruptions for patients decision. At Cox Model, adjusted by demographic and laboratory variables, DRV/r and ATV/r significantly reduced the likelihood of TD and longer treatment was associated with lower risk, while low CD4 count at baseline and number of previous regimens with a higher risk. Moreover, RAL and 3TC use were significantly associated with lower TD by toxicity.\nCONCLUSIONS: In our clinical practice experience, switching virologically suppressed patients to PI/r based DT showed adequate safety and efficacy, so that it may be used in selected patients with specific medical needs.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12879-016-1703-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024946", 
        "issn": [
          "1471-2334"
        ], 
        "name": "BMC Infectious Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study", 
    "pagination": "401", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "931c633bb1e44a3db8b9c035f7d4426d7a0dd3244ffb9d92e77c20b01b6df5e2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27515949"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968551"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12879-016-1703-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030880501"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12879-016-1703-z", 
      "https://app.dimensions.ai/details/publication/pub.1030880501"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70031_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12879-016-1703-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12879-016-1703-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12879-016-1703-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12879-016-1703-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12879-016-1703-z'


 

This table displays all metadata directly associated to this object as RDF triples.

338 TRIPLES      21 PREDICATES      76 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12879-016-1703-z schema:about N1360181d37e14041bf3379ca3d219724
2 N16de259ba73e4b7eb5ead008d8310d51
3 N18713675dc524c6da91d97c77cb065c0
4 N230a759ae065478bbd4e3035ce0ab7af
5 N24d8875d1d6146ac9c0465c540c968a3
6 N433a0fa9a9aa4f78a78f618d283bd8b7
7 N50a5b6b6dd68445587dd9ce428cf4b9b
8 N5a36ca762fac43079d8bada3098035f4
9 N5d18e4338f6e437b8f4a39e567ea5821
10 N666e2d86d8414fe1aab43c888d2a8ee5
11 N6d833ffe888049d78627bfc5ef4c607a
12 N7ebf84ca5dac4928a4cd78514608e6db
13 N964b329d495849fdbccb93ddd10db061
14 Nb137282f05024e5598a24b599677e121
15 Nc63f444c66144b64ab170cc014d63531
16 Ne2e596e65f8f4b93aaa3b7ae71f2e701
17 Nf3dd23538d6b4aea92d7313cbec58f7f
18 Nf40bdaa99d9b4f688a57ddc26a0d1313
19 Nf9f8efb1d7b045cc90d7733a5f1dc137
20 Nfada6e30afa14c31baa47d54f3b90e0c
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author Nd875a88b55db4478a6516c719fd90ab3
24 schema:citation sg:pub.10.1007/s15010-015-0764-z
25 sg:pub.10.1007/s40273-014-0173-7
26 https://app.dimensions.ai/details/publication/pub.1078600806
27 https://doi.org/10.1016/s0140-6736(14)61170-3
28 https://doi.org/10.1016/s1473-3099(14)70736-4
29 https://doi.org/10.1016/s1473-3099(15)00097-3
30 https://doi.org/10.1089/aid.2011.0275
31 https://doi.org/10.1089/aid.2011.0336
32 https://doi.org/10.1093/aje/153.9.898
33 https://doi.org/10.1093/cid/ciw207
34 https://doi.org/10.1093/jac/dkr504
35 https://doi.org/10.1093/jac/dks057
36 https://doi.org/10.1097/00002030-200003310-00005
37 https://doi.org/10.1097/qad.0000000000000407
38 https://doi.org/10.1097/qad.0b013e3283324283
39 https://doi.org/10.1097/qad.0b013e32834bbaa9
40 https://doi.org/10.1097/qai.0b013e31818c7e8e
41 https://doi.org/10.1111/hiv.12129
42 https://doi.org/10.1111/j.1468-1293.2009.00752.x
43 https://doi.org/10.1111/j.1468-1293.2012.00989.x
44 https://doi.org/10.1310/hct1303-119
45 https://doi.org/10.1310/hct1504-140
46 https://doi.org/10.1371/journal.pone.0106221
47 https://doi.org/10.7448/ias.17.4.19788
48 https://doi.org/10.7448/ias.17.4.19799
49 https://doi.org/10.7448/ias.17.4.19803
50 https://doi.org/10.7448/ias.17.4.19813
51 schema:datePublished 2016-12
52 schema:datePublishedReg 2016-12-01
53 schema:description BACKGROUND: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-based (PI/r) dual therapy (DT). METHODS: Observational, retrospective switch study in patients successfully treated with triple drugs regimen. Patients switched to PI/r based DT [darunavir (DRV/r), lopinavir (LPV/r) or atazanavir (ATV/r)] plus a second drug: [raltegravir (RAL), maraviroc (MVC) etravirine (ETR), lamivudine (3TC) or tenofovir (TDF)] between 2009 and 2014 were included. The effect of each drug as well as other clinical and virological cofactors over treatment discontinuation (TD) was assessed using survival analysis. RESULTS: Overall, 376 patients were included with mean follow-up of 73 weeks. The most commonly used drugs in DT were DRV/r (63.0 %) and RAL (53.7 %). TD was observed in 77 (20,4 %) patients: 38 (10,1 %) virological failure, 35 (9,3 %) toxicity/intolerance (4 deaths) and 4 (1 %) interruptions for patients decision. At Cox Model, adjusted by demographic and laboratory variables, DRV/r and ATV/r significantly reduced the likelihood of TD and longer treatment was associated with lower risk, while low CD4 count at baseline and number of previous regimens with a higher risk. Moreover, RAL and 3TC use were significantly associated with lower TD by toxicity. CONCLUSIONS: In our clinical practice experience, switching virologically suppressed patients to PI/r based DT showed adequate safety and efficacy, so that it may be used in selected patients with specific medical needs.
54 schema:genre research_article
55 schema:inLanguage en
56 schema:isAccessibleForFree true
57 schema:isPartOf N1997a68f79ef46f98f711ac6292db8d2
58 N699dc8aab52a4c8aaf32b61af8ab24c2
59 sg:journal.1024946
60 schema:name Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study
61 schema:pagination 401
62 schema:productId N15b2466931cd489b842b26994458f6ba
63 N26e755e484504daaa30a5b0707617105
64 N3f49c958ce0c4117b442e95f2d20917e
65 N433c0b5509194fdc91d5de8f7b8acdef
66 Ncc6746cdc3e2494fba785c3c424e029f
67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030880501
68 https://doi.org/10.1186/s12879-016-1703-z
69 schema:sdDatePublished 2019-04-11T12:36
70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
71 schema:sdPublisher N69bd89e6824248839d58c09765319ccb
72 schema:url https://link.springer.com/10.1186%2Fs12879-016-1703-z
73 sgo:license sg:explorer/license/
74 sgo:sdDataset articles
75 rdf:type schema:ScholarlyArticle
76 N1360181d37e14041bf3379ca3d219724 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Proportional Hazards Models
78 rdf:type schema:DefinedTerm
79 N153b800ed4f94a8097c5ddd518c15187 rdf:first sg:person.01167611267.01
80 rdf:rest Ne149ac908d8f406c887fb73a9bc53a7b
81 N15b2466931cd489b842b26994458f6ba schema:name nlm_unique_id
82 schema:value 100968551
83 rdf:type schema:PropertyValue
84 N16de259ba73e4b7eb5ead008d8310d51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Female
86 rdf:type schema:DefinedTerm
87 N17ddc97df56a4889b7d54ec609bc180f rdf:first sg:person.01262750607.52
88 rdf:rest N7f403065ba9341a8acd7203b92c4c8c2
89 N18713675dc524c6da91d97c77cb065c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Middle Aged
91 rdf:type schema:DefinedTerm
92 N1997a68f79ef46f98f711ac6292db8d2 schema:issueNumber 1
93 rdf:type schema:PublicationIssue
94 N230a759ae065478bbd4e3035ce0ab7af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Drug Therapy, Combination
96 rdf:type schema:DefinedTerm
97 N24d8875d1d6146ac9c0465c540c968a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Lamivudine
99 rdf:type schema:DefinedTerm
100 N26e755e484504daaa30a5b0707617105 schema:name pubmed_id
101 schema:value 27515949
102 rdf:type schema:PropertyValue
103 N3f49c958ce0c4117b442e95f2d20917e schema:name doi
104 schema:value 10.1186/s12879-016-1703-z
105 rdf:type schema:PropertyValue
106 N42cbf219c68640a0bf370a7c653c716e rdf:first sg:person.0657532603.19
107 rdf:rest N6220e67f703441ec854bbe651fb5d03d
108 N433a0fa9a9aa4f78a78f618d283bd8b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Lopinavir
110 rdf:type schema:DefinedTerm
111 N433c0b5509194fdc91d5de8f7b8acdef schema:name readcube_id
112 schema:value 931c633bb1e44a3db8b9c035f7d4426d7a0dd3244ffb9d92e77c20b01b6df5e2
113 rdf:type schema:PropertyValue
114 N45db2e67eb4d4bd885bfd3ef683b7dc9 schema:name Policlinico Universitario “Umberto I”, Clinic of Infectious Diseases, Rome, Italy
115 rdf:type schema:Organization
116 N50a5b6b6dd68445587dd9ce428cf4b9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name HIV Protease Inhibitors
118 rdf:type schema:DefinedTerm
119 N58df31d9d5bd47858f1b0fb8ba73b60e schema:name Azienda Ospedaliero Universitaria, Clinic of Infectious Diseases, Modena, Italy
120 rdf:type schema:Organization
121 N5a36ca762fac43079d8bada3098035f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Humans
123 rdf:type schema:DefinedTerm
124 N5d18e4338f6e437b8f4a39e567ea5821 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name HIV Infections
126 rdf:type schema:DefinedTerm
127 N6220e67f703441ec854bbe651fb5d03d rdf:first sg:person.0655305216.76
128 rdf:rest N7b2fb7dd9efe49269b71dc854b025f00
129 N666e2d86d8414fe1aab43c888d2a8ee5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Tenofovir
131 rdf:type schema:DefinedTerm
132 N699dc8aab52a4c8aaf32b61af8ab24c2 schema:volumeNumber 16
133 rdf:type schema:PublicationVolume
134 N69bd89e6824248839d58c09765319ccb schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 N6c7cf22cfd0343698617cc657fcb73aa rdf:first sg:person.0727131026.73
137 rdf:rest N17ddc97df56a4889b7d54ec609bc180f
138 N6d833ffe888049d78627bfc5ef4c607a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Anti-HIV Agents
140 rdf:type schema:DefinedTerm
141 N7b2fb7dd9efe49269b71dc854b025f00 rdf:first sg:person.0675523721.85
142 rdf:rest Ncc21fb99eaa544e298e5217f1d24cef3
143 N7ebf84ca5dac4928a4cd78514608e6db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Risk
145 rdf:type schema:DefinedTerm
146 N7f403065ba9341a8acd7203b92c4c8c2 rdf:first sg:person.01151343322.29
147 rdf:rest N153b800ed4f94a8097c5ddd518c15187
148 N964b329d495849fdbccb93ddd10db061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name CD4 Lymphocyte Count
150 rdf:type schema:DefinedTerm
151 N9f64cef793d84849b434914fb7b303ae rdf:first sg:person.01204452374.08
152 rdf:rest N42cbf219c68640a0bf370a7c653c716e
153 Nb137282f05024e5598a24b599677e121 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Retrospective Studies
155 rdf:type schema:DefinedTerm
156 Nba999e5d8569467eb279712ac60fd102 rdf:first sg:person.01012755035.52
157 rdf:rest Neecf8d0511574f5190bd000a0625ed1d
158 Nc63f444c66144b64ab170cc014d63531 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Raltegravir Potassium
160 rdf:type schema:DefinedTerm
161 Ncc21fb99eaa544e298e5217f1d24cef3 rdf:first sg:person.01160510471.36
162 rdf:rest rdf:nil
163 Ncc6746cdc3e2494fba785c3c424e029f schema:name dimensions_id
164 schema:value pub.1030880501
165 rdf:type schema:PropertyValue
166 Nd875a88b55db4478a6516c719fd90ab3 rdf:first sg:person.0654670657.55
167 rdf:rest N6c7cf22cfd0343698617cc657fcb73aa
168 Ne149ac908d8f406c887fb73a9bc53a7b rdf:first sg:person.0630766224.01
169 rdf:rest Nf8729fa0f87c42e7a0f1468c696bc99b
170 Ne2e596e65f8f4b93aaa3b7ae71f2e701 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Male
172 rdf:type schema:DefinedTerm
173 Neecf8d0511574f5190bd000a0625ed1d rdf:first sg:person.0647671457.37
174 rdf:rest N9f64cef793d84849b434914fb7b303ae
175 Nf3dd23538d6b4aea92d7313cbec58f7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Antiretroviral Therapy, Highly Active
177 rdf:type schema:DefinedTerm
178 Nf40bdaa99d9b4f688a57ddc26a0d1313 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Follow-Up Studies
180 rdf:type schema:DefinedTerm
181 Nf8729fa0f87c42e7a0f1468c696bc99b rdf:first sg:person.01226673662.15
182 rdf:rest Nba999e5d8569467eb279712ac60fd102
183 Nf9f8efb1d7b045cc90d7733a5f1dc137 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Darunavir
185 rdf:type schema:DefinedTerm
186 Nfada6e30afa14c31baa47d54f3b90e0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Medication Adherence
188 rdf:type schema:DefinedTerm
189 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
190 schema:name Medical and Health Sciences
191 rdf:type schema:DefinedTerm
192 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
193 schema:name Clinical Sciences
194 rdf:type schema:DefinedTerm
195 sg:journal.1024946 schema:issn 1471-2334
196 schema:name BMC Infectious Diseases
197 rdf:type schema:Periodical
198 sg:person.01012755035.52 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
199 schema:familyName Ammassari
200 schema:givenName Adriana
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012755035.52
202 rdf:type schema:Person
203 sg:person.01151343322.29 schema:affiliation https://www.grid.ac/institutes/grid.24704.35
204 schema:familyName Sterrantino
205 schema:givenName Gaetana
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151343322.29
207 rdf:type schema:Person
208 sg:person.01160510471.36 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
209 schema:familyName Zaccarelli
210 schema:givenName Mauro
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160510471.36
212 rdf:type schema:Person
213 sg:person.01167611267.01 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
214 schema:familyName Giannetti
215 schema:givenName Alberto
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167611267.01
217 rdf:type schema:Person
218 sg:person.01204452374.08 schema:affiliation https://www.grid.ac/institutes/grid.414603.4
219 schema:familyName Colafigli
220 schema:givenName Manuela
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204452374.08
222 rdf:type schema:Person
223 sg:person.01226673662.15 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
224 schema:familyName Loiacono
225 schema:givenName Laura
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226673662.15
227 rdf:type schema:Person
228 sg:person.01262750607.52 schema:affiliation N58df31d9d5bd47858f1b0fb8ba73b60e
229 schema:familyName Borghi
230 schema:givenName Vanni
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262750607.52
232 rdf:type schema:Person
233 sg:person.0630766224.01 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
234 schema:familyName Lorenzini
235 schema:givenName Patrizia
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630766224.01
237 rdf:type schema:Person
238 sg:person.0647671457.37 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
239 schema:familyName Bellagamba
240 schema:givenName Rita
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647671457.37
242 rdf:type schema:Person
243 sg:person.0654670657.55 schema:affiliation https://www.grid.ac/institutes/grid.414603.4
244 schema:familyName Latini
245 schema:givenName Alessandra
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654670657.55
247 rdf:type schema:Person
248 sg:person.0655305216.76 schema:affiliation https://www.grid.ac/institutes/grid.8142.f
249 schema:familyName Di Giambenedetto
250 schema:givenName Simona
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655305216.76
252 rdf:type schema:Person
253 sg:person.0657532603.19 schema:affiliation N45db2e67eb4d4bd885bfd3ef683b7dc9
254 schema:familyName D’Ettorre
255 schema:givenName Gabriella
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657532603.19
257 rdf:type schema:Person
258 sg:person.0675523721.85 schema:affiliation https://www.grid.ac/institutes/grid.419423.9
259 schema:familyName Antinori
260 schema:givenName Andrea
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675523721.85
262 rdf:type schema:Person
263 sg:person.0727131026.73 schema:affiliation https://www.grid.ac/institutes/grid.415025.7
264 schema:familyName Fabbiani
265 schema:givenName Massimiliano
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727131026.73
267 rdf:type schema:Person
268 sg:pub.10.1007/s15010-015-0764-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1000109765
269 https://doi.org/10.1007/s15010-015-0764-z
270 rdf:type schema:CreativeWork
271 sg:pub.10.1007/s40273-014-0173-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002540664
272 https://doi.org/10.1007/s40273-014-0173-7
273 rdf:type schema:CreativeWork
274 https://app.dimensions.ai/details/publication/pub.1078600806 schema:CreativeWork
275 https://doi.org/10.1016/s0140-6736(14)61170-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033681539
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1016/s1473-3099(14)70736-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003152007
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1016/s1473-3099(15)00097-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033533736
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1089/aid.2011.0275 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059226372
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1089/aid.2011.0336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059226409
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1093/aje/153.9.898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036832909
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1093/cid/ciw207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059467827
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1093/jac/dkr504 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031544139
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1093/jac/dks057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039666385
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1097/00002030-200003310-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007926797
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1097/qad.0000000000000407 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021587453
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1097/qad.0b013e3283324283 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023348079
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1097/qad.0b013e32834bbaa9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047934667
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1097/qai.0b013e31818c7e8e schema:sameAs https://app.dimensions.ai/details/publication/pub.1036507163
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1111/hiv.12129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030900257
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1111/j.1468-1293.2009.00752.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003494913
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1111/j.1468-1293.2012.00989.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1015370595
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1310/hct1303-119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064986484
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1310/hct1504-140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064986562
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1371/journal.pone.0106221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042054138
314 rdf:type schema:CreativeWork
315 https://doi.org/10.7448/ias.17.4.19788 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021877518
316 rdf:type schema:CreativeWork
317 https://doi.org/10.7448/ias.17.4.19799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041103106
318 rdf:type schema:CreativeWork
319 https://doi.org/10.7448/ias.17.4.19803 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049402120
320 rdf:type schema:CreativeWork
321 https://doi.org/10.7448/ias.17.4.19813 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022776262
322 rdf:type schema:CreativeWork
323 https://www.grid.ac/institutes/grid.24704.35 schema:alternateName Azienda Ospedaliero-Universitaria Careggi
324 schema:name Division of Infectious Diseases, Careggi Hospital, Florence, Italy
325 rdf:type schema:Organization
326 https://www.grid.ac/institutes/grid.414603.4 schema:alternateName Istituti di Ricovero e Cura a Carattere Scientifico
327 schema:name San Gallicano Dermatologic Institute (IRCCS), Clinic of Dermatology and Infectious Diseases, Rome, Italy
328 rdf:type schema:Organization
329 https://www.grid.ac/institutes/grid.415025.7 schema:alternateName Azienda Ospedaliera San Gerardo
330 schema:name Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
331 Division of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy
332 rdf:type schema:Organization
333 https://www.grid.ac/institutes/grid.419423.9 schema:alternateName Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
334 schema:name Clinical Department, National Institute for the Infectious Diseases “Lazzaro Spallanzani”, Rome, Italy
335 rdf:type schema:Organization
336 https://www.grid.ac/institutes/grid.8142.f schema:alternateName Catholic University of the Sacred Heart
337 schema:name Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
338 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...